The atrial septal defect diagnosed in the senility – the benefit of the transcatheter closure (RCD code: IV‑2B.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 5
Abstract
Objective: Closure of the atrial septal defect in the elderly patients is controversial. The aim of the study was to evaluate the outcomes of transcatheter closure of secundum atrial septal defect (ASD) in elderly patients. Methods: From a total of 488 patients with ASD who underwent transcatheter closure 15 pts over 70 years (10 females, 5 males) with a mean age of 75.3 ±12.7 (70–79) were analyzed. All patients had an isolated secundum ASD with a mean Qp:Qs: 3.01 ±1.9 (2.6–3.9). A symptom-limited treadmill exercise tests with respiratory gas exchange analysis and transthoracic color Doppler echocardiographic study as well as Quality of life (QoL) measured using the SF36 questionnaire (SF36q) were repeated in all patients before procedure and after 12 months of follow-up. Results: The atrial septal occluder (ASO) device was successfully implanted in all patients (procedure time 29.7±6.5 (14–59) minutes, fluoroscopy time 13.2 ±9.3(6–40) minutes). There were no major complications. The defect echo diameter was 21.7± 15.8 (18–33) mm. The diameter of the implanted devices ranged 20 – 36 mm. After 12 months of ASD closure, all the patients showed a significant improvement of exercise capacity parameters. Seven QoL parameters (except mental health) improved at 12 months follow up compared to their baseline data. The right ventricular dimension decreased (p<0.005), parameters of exercise capacity improved – oxygen consumption increased (p<0.001). Conclusions: Closure of ASD in elderly patients caused a significant clinical and hemodynamic improvement after percutaneous treatment, which is maintained to long-term follow-up what justified this procedure in old age. JRCD 2015; 2 (5): 144–149
Authors and Affiliations
Monika Komar, Tadeusz Przewlocki, Bartosz Sobień, Urszula Gancarczyk, Paweł Prochownik, Piotr Wilkołek, Maria Olszowska
Keywords
Related Articles
- EP ID EP248043
- DOI 10.20418/jrcd.vol2no5.215
- Views 96
- Downloads 0
31-year old man with Short QT syndrome (RCD code: V-1A.3)
Short QT (SQTS) syndrome is a rare inherited autosomal dominant cardiac channelopathy associated with malignant ventricular and atrial arrhythmias. It is the severest form of the major channelopathies, with cardiac arres...
Pulmonary artery pressure matters – how to efficiently improve survival in pulmonary arterial hypertension (RCD code: II‐1A.1)
Pulmonary arterial hypertension is a disease characterized by poor prognosis despite treatment. Even in a modern era of pharmaco- therapy there is a strong need to further improve survival of patients. The current therap...
4th Symposium on Rare Cardiovascular Diseases – ESC Barcelona 2014
Raport from the Satellite Symposium on Rare Cardiovascular Diseases.
Therapy with sildenafil in a patient with pulmonary hypertension associated with end‑stage left ventricular failure (RCD code: II‑1B.1)
In the last decade the great progress was made in the therapy of pulmonary arterial hypertension (PAH). Unfortunately, there is still lack of evidence-based data how to manage with pulmonary hypertension due to left hear...
Journal of Rare Cardiovascular Diseases: Another exciting quarter in the ‘usual’ life of the Journal
Dear Friends and Colleagues,Our Dear Readers and Supporters of the Journal,It is an extreme pleasure to deliver at your hand the 7th issue of the Journal of Rare Cardiovascular Diseases. Our two‑year anniversary has not...